Submission for OMB Review; 30-Day Comment Request; Evaluation of Office of Acquisitions System (OASYS) and FFRDC Contract Administration System (FCAS) Vendor Portals National Cancer Institute (NCI), 48746-48747 [2021-18767]

Download as PDF 48746 Federal Register / Vol. 86, No. 166 / Tuesday, August 31, 2021 / Notices Director who reports to the Assistant Secretary for Health. 2. OCCHE shall work with the Immediate Office of the Secretary, Staff Divisions, and Operating Divisions to focus on: —Identifying communities with disproportionate exposures to climate hazards and vulnerable populations. —Addressing health disparities exacerbated by climate impacts to enhance community health resilience. —Promoting and translating research on public health benefits of multisectoral climate actions. —Supporting regulatory efforts to reduce greenhouse gas emissions and criteria air pollution throughout the health care sector, including participating suppliers and providers. —Fostering innovation in climate adaptation and resilience for people and communities experiencing a disproportionate share of climate impacts and health inequities. —Providing expertise and coordination to the White House and other Federal agencies related to climate change and health equity deliverables and activities, including executive order implementation, and reporting on health adaptation actions under the United Nations Framework Convention on Climate Change. —Promoting training opportunities to build the climate and health workforce and empower communities. —Exploring opportunities to partner with the philanthropic and private sectors to support innovative programming to address disparities and health sector transformation. Delegations of Authority khammond on DSKJM1Z7X2PROD with NOTICES Directives or orders made by the Secretary or the Assistant Secretary for Health, including all delegations and redelegations of authority made to officials and employees of affected organizational components will continue in force pending further delegation, if allowed, provided they are consistent with this realignment. Andrea Palm, Deputy Secretary. [FR Doc. 2021–18794 Filed 8–30–21; 8:45 am] BILLING CODE 4150–03–P VerDate Sep<11>2014 20:08 Aug 30, 2021 Jkt 253001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Advancing Translational Sciences; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Center for Advancing Translational Sciences Advisory Council. The meeting will be open to the public as indicated below. The open session will be videocast and can be accessed from the NIH Videocasting and Podcasting website (http:// videocast.nih.gov). Individuals who need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Advancing Translational Sciences Advisory Council. Date: September 23–24, 2021. Closed: September 23, 2021, 10:30 a.m. to 12:30 p.m. Agenda: To review and evaluate grant applications. Place: National Center for Advancing Translational Sciences, National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Room 987/989, Bethesda, MD 20892 (Virtual Meeting). Open: September 23, 2021, 1:00 p.m. to 5:00 p.m. Agenda: Report from the Institute Director and other staff. Place: National Center for Advancing Translational Sciences, National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Room 987/989, Bethesda, MD 20892 (Virtual Meeting). Open: September 24, 2021, 1:00 p.m. to 5:00 p.m. Agenda: To view and discuss Clearance of Concepts. Place: National Center for Advancing Translational Sciences, National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Room 987/989, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Anna L. Ramsey-Ewing, Ph.D., Executive Secretary, National Center PO 00000 Frm 00088 Fmt 4703 Sfmt 4703 for Advancing Translational Sciences, One Democracy Plaza, Room 1072, Bethesda, MD 20892, 301–435–0809, anna.ramseyewing@ nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice no later than 15 days after the meeting at NCATSCouncilInput@ mail.nih.gov. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: August 25, 2021. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–18727 Filed 8–30–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Submission for OMB Review; 30-Day Comment Request; Evaluation of Office of Acquisitions System (OASYS) and FFRDC Contract Administration System (FCAS) Vendor Portals National Cancer Institute (NCI) AGENCY: National Institutes of Health, HHS. ACTION: Notice. In compliance with the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. DATES: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. FOR FURTHER INFORMATION CONTACT: Marla Jacobson, 9609 Medical Center Drive, MSC 9742, Rockville, MD 20850 or call non-toll-free number 240–276– SUMMARY: E:\FR\FM\31AUN1.SGM 31AUN1 48747 Federal Register / Vol. 86, No. 166 / Tuesday, August 31, 2021 / Notices 5267 or Email your request, including your address to: marla.jacobson@ nih.gov. Formal requests for additional plans and instruments must be requested in writing. SUPPLEMENTARY INFORMATION: This proposed information collection was previously published in the Federal Register on May 19, 2021, page 27093 (Vol. 86 FR 27093) and allowed 60 days for public comment. No public comments were received. The National Cancer Institute (NCI), National Institutes of Health, may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. Proposed Collection: Evaluation of Office of Acquisitions System (OASYS) email (future OASYS Vendor Portal Users) and were (current FCAS Vendor Portal Users) to individual OA recipients. The FCAS Vendor Portal and in the future, the OASYS Vendor Portal will serve as a one-stop shop for transmission of requests, reports, deliverables and other correspondence due on numerous research and development, in support of R&D contracts as well as those contract vehicles awarded using various Federal Acquisition Procedures including but not limited to FAR Part 8, Required Sources of Supplies and Services, FAR Part 13, Simplified Acquisition Procedures, and FAR Part 12, Acquisition of Commercial Items. These reports and deliverables cover a wide variety of topics in the areas of cancer research including prevention, detection, diagnosis, and control. OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 232. and FFRDC Contract Administration System (FCAS) Vendor Portals National Cancer Institute (NCI), 0925–NEW, Expiration Date XX/XX/XXXX, NEW, National Cancer Institute (NCI), National Institutes of Health (NIH). Need and Use of Information Collection: The National Cancer Institute (NCI) Office of Acquisitions (OA), located within the Office of the Director (OD) in the Office of Management (OM) at the National Cancer Institute (NCI), awards and administers contracts and simplified acquisitions in support of the Institute’s mission to prevent, diagnose and treat cancer. During the acquisition process, the OA ensures that customer service is paramount, and communications are open and continuous. Currently requests and correspondence are sent to and received from vendors through email with the exception of the FFRDC Contractor who submits through the FCAS Vendor Portal which is in production. To streamline processes, increase transparency and gain efficiencies, the OA developed OASYS and FCAS vendor portals to replace processes that are handled through ESTIMATED ANNUALIZED BURDEN HOURS Number of responses per respondent Average time per response (in hours) Total annual burden hours Type of respondent Survey—OASYS ............................... Survey—FCAS .................................. Registration—OASYS ....................... Registration—FCAS .......................... Data Field Information—OASYS ...... Data Field Information—FCAS ......... Add/Edit new Vendor User—OASYS Add/Edit new Vendor User—FCAS .. Individuals ........................................ Individuals ........................................ Corporations ..................................... Corporations ..................................... Individuals ........................................ Individuals ........................................ Corporations ..................................... Corporations ..................................... 10 1 400 1 400 61 40 6 1 1 1 1 18 63 1 1 6/60 6/60 6/60 6/60 1/60 1/60 6/60 6/60 1 1 40 1 120 64 4 1 Totals ......................................... ........................................................... 919 11,501 ........................ 232 Dated: August 26, 2021. Vivian Horovitch-Kelley, Project Clearance Liaison, National Cancer Institute, National Institutes of Health. Maryland, 20892, which was published in the Federal Register on August 4, 2021, FR Doc 2021–16549, 86 FR 41983. This notice is being amended to change the start time for the second Open session on September 1, 2021, which will now be 12:30 p.m. and will still end at 2:30 p.m. as listed. The meeting is closed to the public. [FR Doc. 2021–18767 Filed 8–30–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: August 25, 2021. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. National Institutes of Health khammond on DSKJM1Z7X2PROD with NOTICES Number of respondents Form name National Institute of Environmental Health Sciences; Amended Notice of Meeting [FR Doc. 2021–18725 Filed 8–30–21; 8:45 am] Notice is hereby given of a change in the meeting of the National Heart, Lung, and Blood Advisory Council, August 31, 2021–September 1, 2021, National Institutes of Health, Bethesda, VerDate Sep<11>2014 20:08 Aug 30, 2021 Jkt 253001 BILLING CODE 4140–01–P PO 00000 Frm 00089 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Human Genome Research Institute; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Advisory Council for Human Genome Research. The meeting will be open to the public as indicated below, the 94th meeting of the National Advisory Council for Human Genome Research open session will be livestreamed and available for viewing to the public from https://www.genome.gov/eventcalendar/94th-Meeting-of-NationalAdvisory-Council-for-Human-Genome- E:\FR\FM\31AUN1.SGM 31AUN1

Agencies

[Federal Register Volume 86, Number 166 (Tuesday, August 31, 2021)]
[Notices]
[Pages 48746-48747]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-18767]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Submission for OMB Review; 30-Day Comment Request; Evaluation of 
Office of Acquisitions System (OASYS) and FFRDC Contract Administration 
System (FCAS) Vendor Portals National Cancer Institute (NCI)

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the 
National Institutes of Health (NIH) has submitted to the Office of 
Management and Budget (OMB) a request for review and approval of the 
information collection listed below.

DATES: Comments regarding this information collection are best assured 
of having their full effect if received within 30-days of the date of 
this publication.

ADDRESSES: Written comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.

FOR FURTHER INFORMATION CONTACT: Marla Jacobson, 9609 Medical Center 
Drive, MSC 9742, Rockville, MD 20850 or call non-toll-free number 240-
276-

[[Page 48747]]

5267 or Email your request, including your address to: 
[email protected]. Formal requests for additional plans and 
instruments must be requested in writing.

SUPPLEMENTARY INFORMATION: This proposed information collection was 
previously published in the Federal Register on May 19, 2021, page 
27093 (Vol. 86 FR 27093) and allowed 60 days for public comment. No 
public comments were received. The National Cancer Institute (NCI), 
National Institutes of Health, may not conduct or sponsor, and the 
respondent is not required to respond to, an information collection 
that has been extended, revised, or implemented on or after October 1, 
1995, unless it displays a currently valid OMB control number.
    In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction 
Act of 1995, the National Institutes of Health (NIH) has submitted to 
the Office of Management and Budget (OMB) a request for review and 
approval of the information collection listed below.
    Proposed Collection: Evaluation of Office of Acquisitions System 
(OASYS) and FFRDC Contract Administration System (FCAS) Vendor Portals 
National Cancer Institute (NCI), 0925-NEW, Expiration Date XX/XX/XXXX, 
NEW, National Cancer Institute (NCI), National Institutes of Health 
(NIH).
    Need and Use of Information Collection: The National Cancer 
Institute (NCI) Office of Acquisitions (OA), located within the Office 
of the Director (OD) in the Office of Management (OM) at the National 
Cancer Institute (NCI), awards and administers contracts and simplified 
acquisitions in support of the Institute's mission to prevent, diagnose 
and treat cancer. During the acquisition process, the OA ensures that 
customer service is paramount, and communications are open and 
continuous. Currently requests and correspondence are sent to and 
received from vendors through email with the exception of the FFRDC 
Contractor who submits through the FCAS Vendor Portal which is in 
production. To streamline processes, increase transparency and gain 
efficiencies, the OA developed OASYS and FCAS vendor portals to replace 
processes that are handled through email (future OASYS Vendor Portal 
Users) and were (current FCAS Vendor Portal Users) to individual OA 
recipients. The FCAS Vendor Portal and in the future, the OASYS Vendor 
Portal will serve as a one-stop shop for transmission of requests, 
reports, deliverables and other correspondence due on numerous research 
and development, in support of R&D contracts as well as those contract 
vehicles awarded using various Federal Acquisition Procedures including 
but not limited to FAR Part 8, Required Sources of Supplies and 
Services, FAR Part 13, Simplified Acquisition Procedures, and FAR Part 
12, Acquisition of Commercial Items. These reports and deliverables 
cover a wide variety of topics in the areas of cancer research 
including prevention, detection, diagnosis, and control.
    OMB approval is requested for 3 years. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours are 232.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of     Average time
           Form name                 Type of         Number of     responses per   per response    Total annual
                                   respondent       respondents     respondent      (in hours)     burden hours
----------------------------------------------------------------------------------------------------------------
Survey--OASYS.................  Individuals.....              10               1            6/60               1
Survey--FCAS..................  Individuals.....               1               1            6/60               1
Registration--OASYS...........  Corporations....             400               1            6/60              40
Registration--FCAS............  Corporations....               1               1            6/60               1
Data Field Information--OASYS.  Individuals.....             400              18            1/60             120
Data Field Information--FCAS..  Individuals.....              61              63            1/60              64
Add/Edit new Vendor User--      Corporations....              40               1            6/60               4
 OASYS.
Add/Edit new Vendor User--FCAS  Corporations....               6               1            6/60               1
                                                 ---------------------------------------------------------------
    Totals....................  ................             919          11,501  ..............             232
----------------------------------------------------------------------------------------------------------------


    Dated: August 26, 2021.
Vivian Horovitch-Kelley,
Project Clearance Liaison, National Cancer Institute, National 
Institutes of Health.
[FR Doc. 2021-18767 Filed 8-30-21; 8:45 am]
BILLING CODE 4140-01-P